Skip to content

The effect of aerosol inhalation of esketamine on postoperative sore throat in patients with general anesthesia and intubation

The effect of aerosol inhalation of esketamine on postoperative sore throat in patients with general anesthesia and intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059844
Enrollment
Unknown
Registered
2022-05-12
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sore throat

Interventions

Control group:Normal saline 5.0 ml nebulized
Experimental group:Esketamine aerosol inhalation

Sponsors

Wuhu First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. Age 18-65 years old, no gender restrictions; 3. The operation was performed in the supine position under general anesthesia, and the estimated operation time was 1 to 3 hours.

Exclusion criteria

Exclusion criteria: 1. Refusal by patients or relatives; 2. Known allergy to the drugs used in the study; 3. There are contraindications to the drugs used in the study; 4. Obvious heart, respiratory, liver or kidney dysfunction; 5. Neuromuscular diseases; 6. Recent sore throat; 7. Patients with expected difficult airway; 8. Having head, neck or oral surgery; 9. Mallampati grade is greater than 2; 10. Pregnant and lactating women; 11. Recent use of non-steroidal anti-inflammatory drugs; 12. Patients with more than two intubation attempts.

Design outcomes

Secondary

MeasureTime frame
Mean arterial pressure, MAP;Heart Rate (HR);Plasma Esketamine Concentrations;Age;Gender;Body Mass Index;ASA status;Diagnosis;Operation time;Time of anesthesia;Other complications;

Primary

MeasureTime frame
Postoperative sore throat;

Countries

China

Contacts

Public ContactXie Ben-Fa

Wuhu First People's Hospital

936168553@qq.com+86 14755370046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026